Neuroendocrine Carcinoma Survivor - Susan's Envita Review
Susan came to Envita in a wheelchair suffering from a rare form of cancer known as neuroendocrine carcinoma, feeling frail, weak, and dehydrated, but after completing her personalized treatment she is heading home with no signs of cancer in her body. “On the last PET scan there was no sign of cancer. They knew what to have me do, to get well,” said Susan, about the doctors who treated her at Envita Medical Centers, a world-class integrative center of precision oncology, located in Scottsdale, Arizona.
Disclaimer: Individual results will vary. Envita makes no guarantees for outcomes. Each patient case is unique. Please consult your doctor before making any changes to your medical treatment. Not every patient is a candidate for care or achieves these results. Treatments used in this case may not all be FDA approved for the treatment of this condition.
Her Envita Connection
Susan had approached her conventional doctors with symptoms of bowel pain and a lump on her pubic bone, so they had suggested an ultrasound which revealed a uterine fibroid tumor. Susan's physicians recommended a hysterectomy, a highly invasive surgical procedure to remove the uterus. “I didn't really like the idea of doing that,” said Susan. She wanted a precision approach that was less invasive than standard surgery and began researching facilities that offer tumor embolization. Fortunately, Susan had personally heard of Envita's success from her colleagues. “By then I was very weak, not holding any food down or water, so I didn't know if I could even fly in the plane,” said Susan, but she was determined to come to Envita for her personalized treatment plan.
Going to the Root of Cancer
“When I first came to Envita, I could hardly talk, but the nurses kicked right in and started getting me going,” said Susan. The expert team at Envita used a combination of cutting-edge conventional treatments along with next level natural therapies to target Susan's specific cancer drivers and tackle the disease at its core. They custom-built her medications based on an extensive genetic analysis of her unique cancer expression. This analysis helped them unravel the cause of the cancer so they could attack it from all possible angles.
Envita's Proprietary Precision Oncology Treatments
Susan underwent a combination of Envita's proprietary suite of precision cancer treatments like Genetically Targeted Fractionated Chemotherapy (GTFC™) and Chemo Immuno Precision Injections (CIPI™). GTFC™ is a metronomically dosed chemotherapy which is directed at the cancer cells, so the healthy cells remain intact and do not weaken the immune system. A strong and healthy immune system is crucial in the fight against cancer because it can prevent further growth and spread of cancer.
CIPI™, a precision form of tumor chemoembolization, is used to cut off the blood supply of the tumor, shutting it down intratumorally. In this interventional radiology procedure, genetically targeted chemo and immuno agents are pushed through a tiny catheter directly inside the tumor. The direct delivery of these agents kills the tumor and produces a systemic response throughout the body, so your body is now equipped to identify and attack cancer cells, helping you stay in long term remission. “I'm amazed and very pleased to be here,” said Susan, who is happy to be cancer-free now. She believes in spreading the message about her journey to recovery and how Envita's unique treatment helped her regain her health, which is why she has written in detail about why she came to “Arizona for treatment?”
Call us Today
Envita's sophisticated treatment algorithm has helped Susan in her battle against cancer. The expert team at Envita including oncologists, interventional radiologists, researchers, and pharmacists work relentlessly to build a unique medical blue print best suited for each patient's specific cancer cell mutations. If you or any of your loved ones have questions regarding cancer, please feel free to call us at 866-830-4576.
Patient Journey Update
Susan's journey is a testament to resilience and the potential of Envita Medical Centers' precision integrative oncology. Diagnosed with aggressive neuroendocrine cancer, she faced immense challenges but remained steadfast in her hope for recovery. Since entering remission in 2022, Susan has continued with targeted follow-up care, designed to sustain her health and prevent recurrence. Her story highlights the importance of a customized, genomics-driven approach, which has played a crucial role in her remission. At Envita, we're honored to have been a part of Susan's journey, supporting her every step of the way to better health
Disclaimer: Individual results will vary. Envita makes no guarantees for outcomes. Each patient case is unique. Please consult your doctor before making any changes to your medical treatment. Not every patient is a candidate for care or achieves these results. Treatments used in this case may not all be FDA approved for the treatment of this condition.
